Gastrointestinal infections caused by cytomegalovirus

Current Infectious Disease Reports

Volumn 5, Issue 2, 2003, Pages 101-107

  Bobak, David A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIDOFOVIR; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; GUANINE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; VALGANCICLOVIR; VIRUS RNA;

ANTIVIRAL ACTIVITY; CENTRAL NERVOUS SYSTEM DISEASE; COLITIS; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; ESOPHAGITIS; GASTROINTESTINAL INFECTION; HEPATITIS; HIGH RISK PATIENT; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LIVER TOXICITY; NONHUMAN; ORGAN TRANSPLANTATION; PANCYTOPENIA; POLYMERASE CHAIN REACTION; RECIPIENT; RETROSPECTIVE STUDY; REVIEW; SEROLOGY; VIRUS CULTURE;

EID: 3142632095     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-003-0044-4     Document Type: Review

References (53)

1. Pass RF: Cytomegalovirus. Pediatr Rev 2002, 23:163-170. Excellent overview of CMV.
2. Sissons JGP, Carmichael AJ: Clinical aspects and management of cytomegalovirus infection. J Infection 2002, 44:78-83.
3. Pass RF: Cytomegalovirus. In Fields Virology. Edited by Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2001:2675-2706.
4. Mocarski ES, Courcelle CT: Cytomegaloviruses and their replication. In Fields Virology. Edited by Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2001:2629-2674.
5. Mocarski ES: Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 2002, 10:332-339.
6. Beisser PS, Goh CS, Cohen FE, Michelson S: Viral chemokine receptors and chemokines in human cytomegalovirus trafficking and interaction with the immune system. CMV chemokine receptors. Curr Top Microbiol Immunol 2002, 269:203-234.
7. Miller DM, Cebulla CM, Sedmark DD: Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. Curr Top Microbiol Immunol 2002, 269:153-170.
8. Grangeot-Keros L, Cointe D: Diagnosis and prognostic markers of HCMV infection. J Clin Virol 2001, 21:213-221.
9. Razonable RR, Rivero A, Rodriguez A, et al.: Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol 2002, 40:746-752.
10. Singh N: Cytomegalovirus infection of liver transplant recipients: comparison of antigenemia and molecular biology assays. Liver Transplant 2001, 7:1004-1007.
11. Zaia J: Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. Clin Infect Dis 2002, 35:999-1004.
12. Humar A, Kumar D, Bolvin G, Calliendo AM: Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002,186:829-833.
13. Rayes N, Seehofer D, Schmidt CA, et al.: Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment? Transplant Proc 2001; 33:1804.
14. Koetz AC, Delbruck R, Furtwangler A, et al.: Cytomegalovirus pp65 antigen-guided preemptive therapy with ganciclovir in solid organ transplant recipients: a prospective, double-blind, placebo-controlled study. Transplantation 2001, 72:1325-1327.
15. Singh, N: Preemptive therapy for cytomegalovirus with oral ganciclovir after liver transplantation. Transplantation 2002, 73:1977-1978.
16. Paya C, Wilson J, Espy M, et al.: Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial. J Infect Dis 2002, 185:854-860.
17. McGavin JK, Goa KL: Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 2001, 61:1153-1183.
18. Drew WL, Paya CV, Emery V: Cytomegalovirus (CMV) resistance to antivirals. Am J Transplant 2001, 1:307-312.
19. Emery VC: Progress in understanding cytomegalovirus drug resistance. J Clin Virol 2001, 21:223-228.
20. Limaye A: Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin Infect Dis 2002, 35:866-872.
21. Lurain N, Bhorade M, Pursell K, et al.: Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. J Infect Dis 2002,186:760-768.
22. Griffiths PD: Cytomegalovirus therapy: current constraints and future opportunities. Curr Opin Infect Dis 2001, 14:765-768.
23. Khare MD, Sharland M: Cytomegalovirus treatment options in immunocompromised patients. Expert Opin Pharmacother 2001, 2:1247-1257.
24. Curran M, Noble S: Valganciclovir. Drugs 2001, 61:1145-1150.
25. Segarra-Newnham M, Salazar MI: Valganciclovir: a new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals. Pharmacotherapy 2002, 22:1124-1128.
26. van der Bij W, Speich R: Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis 2001, 33(Suppl 1):S32-S37.
27. Morales E, Andres A, Gonzalez E, et al.: Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy. Transplant Proc 2002, 34:73-74.
28. Martinez A, Castro A, Gil C, Perez C: Recent strategies in the development of new human cytomegalovirus inhibitors. Med Res Rev 2001, 21:227-244.
29. Emery VC, Hassan-Walker AF: Focus on new drugs in development against human cytomegalovirus. Drugs 2002, 62:1853-1858.
30. Temperton NJ: DNA vaccines against cytomegalovirus: current progress. Int J Antimicrobial Agents 2002, 19:169-172.
31. Karakozis S, Gongor E, Caceres M, et al.: Life-threatening cytomegalovirus colitis in the immunocompetent patient: report of a case and review of the literature. Dis Colon Rectum 2001, 44:1716-1720.
32. Ng FH, Chau TN, Cheung TC, et al.: Cytomeglovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci 1999, 44:945-952.
33. Gill AJ, Eckstein RE: Cytomegalovirus mimicking fulminant colitis in a patient with chronic ulcerative colitis- a case report and review of the incidence in 14 patients with the clinical syndrome of fulminant colitis. Pathol Int 2001, 51:A4.
34. Bloomfeld RS: Are we missing CMV infections in patients hospitalized with severe colitis? Inflamm Bowel Dis 2001, 7:348-349.
35. Olofinlade O, Chiang C: Cytomegalovirus infection as a cause of pseudomembrane colitis: a report of four cases. J Clin Gastroenterol 2001, 32:82-84.
36. Battaglino MP, Rockey DC: Cytomegalovirus colitis presenting with the endoscopic appearance of pseudomembranous colitis. Am Soc Gastrointest Endosc 1999, 50:697.
37. Page M, Dreese J, Poritz L, Koltun W: Cytomegalovirus enteritis: a highly lethal condition requiring early detection and intervention. Dis Colon Rectum 1998, 41:619-623.
38. Vega R, Bertran X, Menacho E, et al.: Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999, 94:1053-1056.
39. Cottone M, Pietrosi G, Martorana A, et al.: Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001, 96:773-775.
40. Kaufman H, Kahn A, Jacobuzio-Donahue C, et al.: Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 1999, 42:24-30.
41. Pfau P, Kochman M, Furth E, et al.: Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naïve patient. Am J Gastroenterol 2001, 96:895-899.
42. Papadakis K, Tung J, Binder S, et al.: Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:2137-2142.
43. Ljungman P, Griffiths P, Paya C: Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34:1094-1097.
44. Castiglione F, Del Vecchio Blanco G, Rispo A, et al.: Hepatitis related to cytomegalovirus infection in two patients with Crohn's disease treated with azathioprine. Dig Liver Dis 2000, 32:626-629.
45. Chan A, Dieckhaus KD, Ramsey W: Cytomegalovirus hepatitis in a nontransplant patient with autoimmune hepatitis taking immunosuppressants. Am J Gastroenterol 2001, 96:262-263.
46. Ohkuchi A, Minakami H, Suzuki I, et al.: Liver dysfunction in late pregnancy: cytomegalovirus-induced hepatitis or the HELLP syndrome? J Obstet Gynaecol Res 2001, 27:319-323.
47. Revello MG, Gerna G: Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002, 15:680-715.
48. Funato T, Satou N, Abukawa D, et al.: Quantitative evaluation of cytomegalovirus DNA in infantile hepatitis. J Viral Hepatitis 2001, 8:217-222.
49. Tajiri H, Kozaiwa K, Tanaka-Taya K, et al.: Cytomegalovirus hepatitis confirmed by in situ hybridization in 3 immunocompetent infants. Scand J Infect Dis 2001, 33:790-793.
50. Varani S, Lazzarotto T, Margotti M, et al.: Laboratory signs of acute or recent cytomegalovirus infection are common in cirrhosis of the liver. J Med Virol 2000, 62:25-28.
51. Teixeira R, Pastacaldi S, Davies S, et al.: The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation. Transplantation 2000, 70:1454-1458.
52. Burak KW, Kremers WK, Batts KP, et al.: Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transplant 2002, 8:362-369.
53. Razonable RR, Burak K, van Cruijsen H, et al.: The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis 2002, 35:974-981.